Emerging Role of CD44 Receptor as a Potential Target in Disease Diagnosis: A Patent Review
Author:
Affiliation:
1. Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi- 110 062, India
2. Department of Pharmacology, Vallabhbhai Patel Chest Institute, University of Delhi, Delhi -110 007, India
Publisher
Bentham Science Publishers Ltd.
Subject
Drug Discovery,General Medicine,Immunology and Allergy
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Nanocarrier-Based Targeting of Cluster of Differentiation 44 for Treating Atherosclerosis: A Review;Journal of Biomedical Nanotechnology;2023-03-01
2. Exploring the applications of hyaluronic acid‐based nanoparticles for diagnosis and treatment of bacterial infections;WIREs Nanomedicine and Nanobiotechnology;2022-04-29
3. Targeted co-delivery biomimetic nanoparticles reverse macrophage polarization for enhanced rheumatoid arthritis therapy;Drug Delivery;2022-04-01
4. SNX5 suppresses clear cell renal cell carcinoma progression by inducing CD44 internalization and epithelial-to-mesenchymal transition;Molecular Therapy - Oncolytics;2022-03
5. Recent advances in nanoparticle-based drug delivery systems for rheumatoid arthritis treatment;Nanoscale Advances;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3